Tumor Research Institute of Hebei Province

Shijiazhuang, China

Tumor Research Institute of Hebei Province

Shijiazhuang, China

Time filter

Source Type

Wu L.-H.,Tumor Research Institute of Hebei Province | Zhang C.,Tumor Research Institute of Hebei Province | Shan B.-E.,Tumor Research Institute of Hebei Province | Liu L.-H.,Tumor Research Institute of Hebei Province | Ai J.,Tumor Research Institute of Hebei Province
Chinese Journal of Cancer Biotherapy | Year: 2010

Objective: To explore the in vitro and in vivo effects of CD40L-expressing murine colon cancer colon26 vaccine on activities of dendritic cells (DCs). Methods: The CD40L gene was transfected into colon26 cells using lipofactamine method, and the stable colon26/CD40L transfectants were obtained. Colon26/CD40L cells were co-cultured with DCs, and the phenotype of DCs was examined by flow cytometry; the expressions of cytokine genes such as IL-12, IL-23, IL-18 and IFN-γ were examined by RT-PCR; and the IL-12, IL-23 and IFN-γ levels in co-cultured supernatants were measured by ELISA. Tumor-bearing BALB/c mouse model was prepared by subcutaneous injection of colon26 cells, and treated with DCs impulsed with colon26/CD40L vaccine. IL-12, IL-23, IFN-γ, IL-10 and TGF-β levels in mouse peripheral blood were detected by ELISA; and the histopathological changes of the liver, spleen and tumor tissues were observed by H-E staining. Results: Colon26 cells stably expressing CD40L (colon26/CD40L vaccine) were successfully obtained. DCs, when co-cultured with colon26/CD40L vaccine, had up-regulated expressions of co-stimulatory molecules, including CD80, CD86, MHC I and MHC (II (P < 0.01). The expressions of IL-12, IL-23, IL-18 and IFN-γ mRNA genes were only detected in DC-colon26/CD40L system, not in other co-cultured systems. And the DC-colon26/CD40L co-cultured system showed higher IL-12, IL-23 and IFN-γ levels (P < 0.01). Compared with mice treated with colon26/CD40L or DCs, mice treated with DCs-colon26/CD40L had smaller tumor volumes and lower weights (P < 0.05), increased IL-12, IL-23, and IFN-γ levels in the peripheral blood (P < 0.01), decreased IL-10 and TGF-β levels (P < 0.01), and better histopathological changes of tumor tissues. Conclusion: CD40L-expressing colon cancer cells can promote the maturation, induce the cytokine secretion, and enhance the activities of DCs in vitro and in vivo.

Loading Tumor Research Institute of Hebei Province collaborators
Loading Tumor Research Institute of Hebei Province collaborators